06185.HK
CanSino Biologics Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 29.22
−0.61%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- HKD 0.29
- Revenue estimate
- HKD 465.7M
Latest reported
- Last report date
- Aug 27, 2026
- EPS actual
- HKD 0.19
- EPS estimate
- HKD 0.24
- Revenue actual
- HKD 411.5M
- Revenue estimate
- HKD 360.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -21.7%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 30, 2027